Personalised mRNA cancer vaccine prolongs survival in melanoma
Drug Discovery World
APRIL 16, 2023
Vaccine strategies over the last 25 years attempted to induce immune responses against tumour-associated antigens that are not absolutely specific to the tumour,” said presenting author Jeffrey Weber, Deputy Director of the NYU Langone Perlmutter Cancer Center and Laura and Isaac Perlmutter Professor of Oncology at NYU Grossman School of Medicine.
Let's personalize your content